anmelden
FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.04.22 | Unilever Underweight | JP Morgan Chase & Co. | |
| 21.04.22 | HSBC Hold | Jefferies & Company Inc. | |
| 21.04.22 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 21.04.22 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.04.22 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 20.04.22 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 20.04.22 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 20.04.22 | HSBC Overweight | Barclays Capital | |
| 20.04.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 20.04.22 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 19.04.22 | GSK Buy | Jefferies & Company Inc. | |
| 19.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 19.04.22 | Diageo Overweight | JP Morgan Chase & Co. | |
| 19.04.22 | BP Overweight | JP Morgan Chase & Co. | |
| 19.04.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 13.04.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Vodafone Group Buy | UBS AG | |
| 12.04.22 | Prudential Buy | UBS AG | |
| 12.04.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.22 | HSBC Neutral | Credit Suisse Group | |
| 12.04.22 | Diageo Overweight | JP Morgan Chase & Co. | |
| 11.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.04.22 | Barclays Outperform | Credit Suisse Group | |
| 11.04.22 | GSK Neutral | UBS AG | |
| 11.04.22 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 08.04.22 | Diageo Buy | Merrill Lynch & Co., Inc. | |
| 08.04.22 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 08.04.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.04.22 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 08.04.22 | BAT Buy | Goldman Sachs Group Inc. | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 07.04.22 | BAT Buy | UBS AG | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 07.04.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 07.04.22 | BP Outperform | RBC Capital Markets | |
| 07.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.04.22 | Diageo Overweight | JP Morgan Chase & Co. | |
| 06.04.22 | Unilever Sell | UBS AG |